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Aim To report on the successful analysis of amplicons ob-
tained with PowerPlex® Fusion 6C System, a highly robust 
27-plex genotyping kit developed for human identifica-
tion laboratories, on the Applied Biosystems® 3500 Genetic 
Analyzer.
Method We performed characterization and evaluation 
studies following the Scientific Working Group on DNA 
Analysis Methods (SWGDAM) validation guidelines, exam-
ining several critical areas of kit performance. We report 
the results of sensitivity, robustness, heterozygous peak 
height ratio, precision, concordance, caseworks, and mix-
ture interpretations. We tested sensitivity, using serial dilu-
tions of control DNA.
Results The minimum amount of input DNA resulting 
in a full profile was 125 pg. Inhibition, inducted by urea, 
showsed a progressively fragmentation of DNA and a full 
profile was obtained until 1M of inhibitor factor. To test the 
profile quality, casework samples were extracted with dif-
ferent extraction methods: Chelex®100, QIAmp DNA Micro 
Kit and Phenol-Chloroform extraction. The results demon-
strated that extraction chemistries do not have affect on 
amplification performance. Concordance check was per-
formed by typing some casework samples and comparing 
the typing results with those obtained with other available 
kits. Thus, concordance was expected and supported by 
the data.
Conclusion Reliable DNA typing results can be obtained 
using this new kit, demonstrating its effectiveness and util-
ity in forensic analysis.
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The original Combined DNA Index System (CODIS) data-
base consisting of 13 core short tandem repeat (STR) loci 
(CSF1PO, D3S1358, D5S818, D7S820, D8S1179, D13S317, 
D16S539, D18S51, D21S11, FGA, TH01, TPOX, and vWA) has 
been successful for matching suspects with evidence. How-
ever some situations require inclusion of more loci and in-
creased discrimination, such as mixture interpretation and 
degradation (1). The PowerPlex® Fusion 6C System is a 27-
locus multiplex for human identification applications in-
cluding forensic analysis, relationship testing and research 
use. This six-color system allows co-amplification and fluo-
rescent detection of the 18 autosomal loci in the expand-
ed CODIS core loci (CSF1PO, FGA, TH01, vWA, D1S1656, 
D2S1338, D2S441, D3S1358, D5S818, D7S820, D8S1179, 
D10S1248, D12S391, D13S317, D16S539, D18S51, D19S433 
and D21S11) as well as Amelogenin and DYS391 for gen-
der determination. The Penta D, Penta E, D22S1045, TPOX, 
SE33 loci and the two rapidly mutating Y-STRs, DYS570 and 
DYS576 loci, are also included to increase discrimination, 
satisfying both CODIS and European Standard Set (ESS) 
recommendations (2,3). The new loci may also aid in deter-
mining the number of contributors to a mixture (4).
This kit alleviates a significant bottleneck in genotype 
throughput by eliminating the need for more amplifica-
tions to obtain complete profiles for a particular sample 
through a single tube analysis. The PowerPlex® Fusion 6C 
System is compatible with the Applied Biosystems® 3500 
Genetic Analyzer as reported in the technical manual (5), 
but a validation should be performed.
This paper describes our validation studies conducted with 
PowerPlex® Fusion 6C System, based on internal validation 
criteria in accordance with guidelines issued by the Scien-
tific Working Group on DNA Analysis Methods (SWGDAM) 
(6). We performed sensitivity, inhibited and mixture stud-
ies using control DNA samples and we evaluated the data 
obtained from a set of casework samples previously typed. 
The results of this validation showed that PowerPlex® Fu-
sion 6C System, producing accurate and reproducible STR 
profiles, improved the internal laboratory procedures.
MATERIALS AND METHODS
Sensitivity
2800M Control DNA (Promega, Madison, Wisconsin, USA) 
was serially diluted in 2-fold increments to give the follow-
ing amounts when added at 25 µL per PCR: 1.0 ng, 500 pg, 
250 pg, 125 pg, 62.5 pg, and 31.25 pg total per reaction. 
Two replicate PCRs were prepared and PCR amplifications 
were performed according to manufacturer’s protocol. For 
allele designation and peak height ratio determination a 
175 RFU threshold was used for data.
Inhibited model samples
One model of PCR inhibition, urea, was used to represent 
inhibitory compounds; the inhibitor stock solution was 
prepared as follows: urea (Panreac Quimica S.L.U., Barce-
lona, Espana) 10M in water. PCR samples were prepared 
with 1.0 ng of male 2800M control DNA containing a 
range of inhibitor concentrations: 0M (no inhibition), 1M, 
2M, and 5M of urea. Each condition was tested in dupli-
cate PCRs.
DNA mixture study
In forensic caseworks the evidence often contains a mix-
ture DNA from more than one individual. These mixtures 
can be very challenging to analyze and interpret. For im-
proved mixture interpretation, two rapidly-mutating Y-STR 
loci, DYS570 and DYS576, are included in PowerPlex® Fu-
sion 6C System. To test the performance of this kit with 
DNA mixture samples, a series of mixtures of two different 
human genomic DNAs (male 2800M and female 9947A, 
Promega) was made in different mixing ratios. Mixtures 
were formulated to always give 1.0 ng of total DNA per 25 
µL volume, as manufacturer’s recommended, with ratios of 
minor to major DNAs being 1:1, 1:5 and 1:10 and vice versa. 
For example, the 1:5 mixture contained 167 pg minor and 
833 pg major DNA per reaction. Each mixture samples was 
tested in two PCRs and amplified according to manufac-
turer’s protocol.
Forensic caseworks
In order to evaluate the ability to obtain reliable results, 
some forensic case samples were amplified using Power-
Plex® Fusion 6C System. The consistency of typing results 
was evaluated considering previously typing through al-
ready validated kits such as AmpFlSTR® Identifiler Plus (7), 
AmpFlSTR® NGM PCR kits (Life Technologies, Carlsbad, CA, 
USA), PowerPlex® 16 HS System (8) or PowerPlex® ESX 17 
System (9) (Promega, Madison, WI, USA)). DNA concentra-
tion was determined by measuring the absorbance of the 
sample at 260 nm, using the spectrophotometer Nano-
Drop 1000 (ThermoScientific, Waltham, Massachusetts, 
USA). All samples were amplified following manufac-
turer’s protocols.
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Compatibility with different DNA extraction chemistries
Tested samples were extracted from a variety of sources 
by Chelex®100 (BIORAD, Richmond, CA, USA) (10), QIAamp 
DNA Micro Kit (Qiagen, GmbH, Hilden, Germany) (11) and 
Phenol-Chloroform extraction (12).
The detection was performed on an Applied Biosystems® 
3500 Series Genetic Analyzer and data were analyzed with 
GeneMapper® ID-X software.
Sizing precision
Sizing precision is fundamental to an accurate genotyping. 
The injection of the internal lane standard is the basis of an 
STR-typing system’s precision and essential to ensure geno-
typing accuracy. Sizing precision of the WEN ILS 500 size 
standard was evaluated by comparing the size of every allele 
in the allelic ladder over the course of 16 ladder injections 
during a run on Applied Biosystems® 3500 Genetic Analyzer. 
The size of each allele was determined with GeneMapper® 
ID-X v1.4 using the local Southern method. The size was re-
trieved from the genotypes’ tables and introduced into Excel 
spreadsheets to calculate the average and a standard devia-
tion for each allele was plotted against the allele size.
Sample electrophoresis and data analysis
Following thermal cycling, PCR products were prepared 
for capillary electrophoresis (CE) by combining 9.5 µL of Hi-
DiTM Formamide, 0.5 µL of WEN ILS 500 and 1.0 µL of sam-
ple and performed on the 3500 Genetic Analyzer according 
to manufacturer’s manual. Genotyping was performed with 
GeneMapper® ID-X v1.4 software, using the provided panels 
and bin files. For allele designation and peak height ratio de-
termination a 175 RFU threshold was used. In a forensic set-
ting peaks are considered valid for use in statistical analysis 
only above this threshold and it is coherent with our obser-
vation of peak height ratios across multiple loci in dilution 
series of DNA amplified in replicate.
RESULTS
Sensitivity
We examined the sensitivity of the PowerPlex® Fusion 
6C System using serially dilution from 1 ng to 31.25 pg of 
2800M Control DNA. Full allele profiles were obtained for 
2800M at and above level of 125 pg, below which stochastic 
dropout of alleles was observed and partial profiles could 
be observed even at 62.5 pg and 31.25 pg of template DNA. 
For 2800M, the mean allele counts for the lowest DNA level 
tested were 17 alleles out of 47 possible, corresponding to 
the 36.2% of a full profile (Supplemental Figure 1). For peak 
height ratio (PHR) determination loci with homozygous 
peaks and Y-STR’s were excluded from peak height ratio cal-
culations, Amelogenin was also included. When drop out oc-
curred, those loci were also excluded from peak height ratio 
calculations (Figure 1). The measurements for peak height 
were retrieved from the genotypes’ tables and introduced 
FIgURE 1. Peak height ratio analysis. The graph displays the range of peak height ratio for serially dilution in two replicate poly-
merase chain reactions (PCRs) for each locus. The mean of peak height ratio are also shown by red plot. The homozygous peaks and 
short tandem repeats (STR) on the Y-chromosome (Y-STR) were excluded.
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into Excel spreadsheets. The mean percentage heterozy-
gous peak height ratio varied from a low 0.69 (SD 0.40) at 
locus Penta E to a high of 0.91 (SD 0.13) at locus D13S317. At 
least 95% of the observations showed PHR higher than 70% 
including the gender marker.
Inhibited model samples
The robustness was tested using model systems for PCR in-
hibition. The effects of DNA inhibition on the amplification 
efficiency resulted in a progressively fractionated DNA. A 
graphical representation is shown in Supplemental Figure 
2. All replicates of the untreated controls and of the “1M” 
samples gave full profile. Partial profiles could be observed 
for “2M” samples and only a few alleles were obtained with 
the more highly inhibited samples, as reported in Table 1. 
The results are probably due to different effect of inhibitor 
on amplification efficiency for each primer pair (Figure 2).
DNA mixture study
A two-known source DNA mixture was created at various 
ratios and amplified using the recommended protocol, to 
always give 1.0 ng of total DNA per 25 µL volume. Ampli-
fication products were detected using 175 RFU threshold. 
Based on peak height ratio assessments we confirmed the 
ratios for major:minor contributors to the formulated mix-
ture. Following the relevant features for the assessment of 
mixed DNA profiles reported in literature (13), which de-
scribed the criteria for identification of mixed specimens, 
all the alleles of the minor contributor were detected in 
all replicate PCRs of the 1:1, 1:5 and 5:1 mixtures (Figure 
3). Results for the higher mixing ratio samples (1:10 and 
10:1) reflect the stochastic nature of amplifying low input 
DNA levels. The detection limit of the minor component is 
about 10%. In 1:10 mixture (with major female DNA), which 
represents typical case situations, it was even possible to 
detect the presence of male DNA thanks to amplification 
of the Y-STR markers. A representative electropherogram is 
included in Supplemental Figure 3.
Forensic caseworks
To test the reliability of PowerPlex® Fusion 6C System typ-
ing results we amplified 22 forensic case DNA samples, 
from our own collections (Table 2). Furthermore, as DNA 
databases are expanding, reproducibility between STR kits 
is increasingly important to ensure the accuracy of data 
generated with newer kits and maintain the relevance 
of data generated with older ones. The SWGDAM guide-
FIgURE 2. Different effect of inhibitor on amplification efficiency for each locus. The graph shows the different percentage of allele 
detected for each locus in different inhibited samples (1M, 2M, and 5M of urea). The untreated control “0M” gave full alleles (not 
included).
TABLE 1. Amplification efficiency with increasing of urea 
concentration*
Sample Count %Full
0 M 47 100
1 M 47 100
2 M 31  66
5 M  5  11
*In “Sample” column are indicated the inhibitor concentrations. The 
untreated control is designed as “0 M”. “Count” column is the mean 
number of allele detected, and “%Full” column indicates the approxi-
mate percentage of a full profile for the DNA that was represented by 
the mean allele counts. The full profile contained 47 alleles total.
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lines report that results from a new kit studies should be 
compared to the previous results of known samples to en-
sure concordance. Profile quality and sensitivity were not 
compared, since sampling methodology and kit chemis-
try are different. Instead, concordance evaluations are im-
portant to determine if there are any “null alleles” present 
in a data set. Depending on the STR kit configuration the 
placement of the markers can vary between kits because 
the primer sequences were designed to amplify different 
product sizes. This allows concordance testing to be per-
TABLE 2. Case-type samples evaluated with the PowerPlex® Fusion 6C System and comparison of case-type samples previously geno-
typed with other kits (AmpFlSTR® Identifiler Plus, AmpFlSTR® NgM PCR kits, PowerPlex® 16 HS System or PowerPlex® ESX 17 System)
Sample* PowerPlex® Fusion 6C Alleles number Previous typing kit Alleles number Concordance
Buccal swab 47 full profile AmpFlSTR® NGM PCR 37 YES
Blood sample 37 full profile AmpFlSTR® Identifiler® Plus 25 YES
Blood sample 38 full profile PowerPlex® 16 HS System 3 YES
Swab of glove 24 PowerPlex® 16 HS System 27 YES
Swab of glove 17 PowerPlex® 16 HS System 18 YES
Swab of glove 24 PowerPlex® 16 HS System 13 YES
Swab of glove  7 PowerPlex® 16 HS System 0 N/A
Swab of glasses 11 PowerPlex® ESX 17 System 27 YES
Swab of glasses  9 PowerPlex® ESX 17 System 30 YES
Swab of mask 42 PowerPlex® ESX 17 System 13 YES
Swab of mask 20 PowerPlex® ESX 17 System 13 YES
Swab of mask  0 PowerPlex® ESX 17 System 0 N/A
Swab of neckband 16 PowerPlex® ESX 17 System 29 YES
Human tissue 45 full profile AmpFlSTR® Identifiler® Plus 27 YES
Human tissue  8 AmpFlSTR® Identifiler® Plus 19 YES
Blood stain (cloth) 47 full profile AmpFlSTR® Identifiler® Plus 29 YES
Blood stain (cloth) 45 full profile AmpFlSTR® Identifiler® Plus 29 YES
Blood stain (cloth) 46 full profile AmpFlSTR® Identifiler® Plus 30 YES
Case-type mixtures 69 AmpFlSTR® Identifiler® Plus 43 YES
Case-type mixtures 48 AmpFlSTR® Identifiler® Plus 40 YES
Case-type mixtures 70 AmpFlSTR® Identifiler® Plus 43 YES
Case-type mixtures 67 AmpFlSTR® NGM PCR 53 YES
*For each sample, the total number of alleles called with each kit is shown. Where loci had overlap between kits, they were examined for concor-
dance.
FIgURE 3. DNA mixture study. The average percentage of the alleles detected at a given mixture ratio is shown. Error bars represent 
the standard deviation of replicate results.
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formed to compare results obtained between different 
kits. The results of this study were compared with geno-
types previously generated  with other kits (AmpFlSTR® 
Identifiler Plus, AmpFlSTR® NGM, PowerPlex® 16 HS System 
or PowerPlex® ESX 17 System). For all samples amplified 
with PowerPlex® Fusion 6C System, concordance among 
the systems was observed and the typing reliability of the 
new primer sets has been validated. While not an indica-
tion of discordance, the PowerPlex® Fusion 6C System kit 
resulted in more loci designation. This new kit includes 27 
STR markers and increases discrimination, especially in the 
tested mixture samples, where a higher number of allele 
was detected.
Compatibility with DNA extraction chemistries
Tested samples extracted with different analytical meth-
ods (Chelex®100, QIAamp DNA Micro Kit and Phenol-Chlo-
roform extraction), provided profiles in which quality was 
comparable, confirming that different extraction chemis-
tries do not adversely affect the amplification.
Sizing precision
The sizing precision is important for STR fragment analy-
sis since some alleles differ by only 1 base in size. Key per-
formance re quirements for the use of Capillary Electro-
phoresis (CE) for separation and detection of amplified 
fragments are: accurate sizing of fragment over the frac-
tionation range of the STR multiplex amplification system, 
single-base resolution over the fractionation range and 
high run-to-run precision to enable comparison of mobil-
ity of alleles in the allelic lad der to sample’s alleles.  Size pre-
cision of the WEN ILS 500 size standard was evaluated by 
comparing the size of each allele in the allelic ladder over 
the course of 16 ladder injections during a run on the Ap-
plied Biosystems® 3500 Genetic Analyzer. The size of each 
allele was determined with GeneMapper® ID-X v1.4 using 
the local Southern method.
The sizes were averaged, and a standard deviation for each 
allele was plotted against the allele size (Figure 4). The stan-
dard deviation had an approximate uniform trendline for 
all fragment size and did not exceed 0.1 when running on 
the Applied Biosystems® 3500 Genetic Analyzer. Further, 
we did not observe statistically significant differences in 
the sizing precision among different loci and with a con-
fidence interval of 99.7%, the WEN ILS 500 demonstrated 
the accuracy of sizing over the entire fractionation range 
for genotyping. These results showed that the precision 
throughout the assay is adequate to size and distinguish 
alleles which differ by as little as one base. This high level of 
precision provides a measure of reliability.
DISCUSSION
The 27-plex PowerPlex® Fusion 6C System was designed 
to allow human identification applications including fo-
rensic analysis, relationship testing and research use. The 
system combines common and informative loci to over-
FIgURE 4. Precision of WEN ILS 500. The average size (bp) of each allele was plotted against the standard deviation observed across 
16 ladders run during 5 injections on the same day on Applied Biosystems® 3500 genetic Analyzer.
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come typical challenges faced by laboratories, including 
low levels of input DNA, sample inhibitors, degradation 
and mixtures. The PowerPlex® Fusion 6C System includes 
the 23 loci in the expanded CODIS core loci panel (includ-
ing SE33), as well as Penta D and Penta E loci for great-
er discriminatory power, delivering more information in 
demanding forensic, paternity and relationship-testing 
cases. Three Y-STRs, two of which are rapidly mutating, 
were also included to improve mixture interpretation. 
This evaluation study examined many aspects of kit per-
formance, following SWGDAM validation guidelines. The 
results of the performed validation studies demonstrated 
the robustness and reliability of the kit. The amplification 
chemistry of PowerPlex® Fusion 6C System provided accu-
rate profiles and a wide range of input target DNA. Good 
results were also obtained from artificially inhibited sam-
ples and we demonstrated the potential limitations and 
the consistency verifying the accuracy of sizing, without 
statistically significant differences in the sizing precision 
among different loci. Therefore, profiles typed with this 
new kit would be of sufficient quality to be uploaded into 
DNA database and to do new population genetics studies. 
Comparison with other available amplification kits proves 
concordance and the reliability of the new primer set has 
been validated. PowerPlex® Fusion 6C improves the ro-
bustness and efficiency of the multiplex STRs system, such 
as minimizing sample consumption and maximizing in-
formative data output. The greater number of alleles cre-
ates greater specificity and generates more data with the 
same amount of DNA, when compared to previous STR 
typing kits. Moreover the possibility to obtain Y-STRs pro-
files in low ratio male to female mixtures is of particular 
practical case application value. According to the guide-
line of quality assurance standards for forensic DNA test-
ing laboratories, we carried out an internal validation and 
demonstrated reliability of PowerPlex® Fusion 6C system. 
The use of this amplification kit is suitable for the use in 
future casework samples. Additionally the short amplifi-
cation time of this kit combined with the automatic CE 
detection system make it practical for a high-throughput 
workflow that generates good profile and great output 
data in less processing time.
Funding None.
Ethical approval was not required.
Declaration of authorship SC, VC and AB were in charge of technical or-
ganization of the study. AV and NC were in charge of organization aspect 
of the study.
Competing interests All authors have completed the Unified Competing 
Interest form at www.icmje.org/coi_disclosure.pdf (available on request 
from the corresponding author) and declare: no support from any or-
ganization for the submitted work; no financial relationships with 
any organizations that might have an interest in the submitted work in the 
previous years; no other relationships or activities that could appear to have 
influenced the submitted work.
References
1  Butler JM. Advanced topics in forensic DNA typing: methodology. 
Elsevier. 2012.
2 Welch LA, gill P, Phillips C, Ansell R, Morling N, Parson W, et 
al. European Network of Forensic Science Institutes (ENFSI): 
evaluation of new commercial STR multiplexes that include the 
European Standard Set (ESS) of markers. Forensic Sci Int genet. 
2012;6:819-26. Medline:22658771 doi:10.1016/j.fsigen.2012.03.005
3 Hares DR. Expanding the CODIS core loci in the United States. 
Forensic Sci Int genet. 2012;6:e52-4. Medline:21543275 
doi:10.1016/j.fsigen.2011.04.012
4 Coble MD, Bright JA, Buckleton JS, Curran JM. Uncertainty in the 
number of contributors in the proposed new CODIS set. Forensic 
Sci Int genet. 2015;19:207-11. Medline:26275610 doi:10.1016/j.
fsigen.2015.07.005
5 Promega Corporation. Technical manual PowerPlex® Fusion 
6C System. Madison, WI, U.S.A. Available from: http://ita.
promega.com/~/media/files/resources/protocols/technical%20
manuals/101/powerplex%20fusion%206c%20system%20protocol.
pdf. Accessed: February 24, 2017.
6 Scientific Working group on DNA Analysis Methods. Validation 
guidelines for DNA Analysis Methods. Approved at the 
Scientific Working group on DNA Analysis Methods Meeting. 
Fredericksburg, Virginia, U.S.A. December 2012. Available at: http://
swgdam.org/SWgDAM_Validation_guidelines_APPROVED_
Dec_2012.pdf. Accessed: February 24, 2017.
7 Wang DY, Chang CW, Lagac RE, Calandro LM, Hennessy LK. 
Developmental Validation of the AmpFlSTR® Identifiler® Plus PCR 
Amplification Kit: an established multiplex assay with improved 
performance. J Forensic Sci. 2012;57:453-65. Medline:22074494 
doi:10.1111/j.1556-4029.2011.01963.x
8 Ensenberger Mg, Thompson J, Hill CR, Homick K, Kearney 
V, Mayntz-Press KA, et al. Developmental validation of the 
PowerPlex® 16 HS System: an improved 16-locus fluorescent STR 
multiplex. Forensic Sci Int genet. 2010;4:257-64. Medline:20457027 
doi:10.1016/j.fsigen.2009.10.007
9 Tucker VC, Hopwood AJ, Sprecher CJ, McLaren RS, Rabbach 
DR, Ensenberger Mg, et al. Developmental validation of the 
PowerPlex® ESX 16 and PowerPlex® ESX 17 Systems. Forensic 
Sci Int genet. 2012;6:124-31. Medline:21466982 doi:10.1016/j.
fsigen.2011.03.009
10 Walsh PS, Metzger DA, Higuchi R. Chelex 100 as a medium for 
simple extraction of DNA for PCR-based typing from forensic 
material. Biotechniques. 1991;10:506-13. Medline:1867860
11 QIAgEN. QIAamp® DNA Micro Handbook, Hilden, 
germany. Available at: https://www.qiagen.com/it/
resources/resourcedetail?id=085e6418-1ec0-45f2-89eb-
33Cisana et al: PowerPlex® Fusion 6C System
www.cmj.hr
62705f86f963&lang=en.
12 Köchl S, Niederstätter H, Parson W. DNA extraction and 
quantitation of forensic samples using the phenol-chloroform 
method and real-time PCR. Methods Mol Biol. 2005;297:13-30. 
Medline:15570097
13 Budowle B, Onorato AJ, Callaghan TF, Della Manna A, gross 
AM, guerrieri RA, et al. Mixture Interpretation: Defining the 
Relevant Features for guidelines for the Assessment of Mixed 
DNA Profiles in Forensic Casework. J Forensic Sci. 2009;54:810-21. 
Medline:19368620 doi:10.1111/j.1556-4029.2009.01046.x
